Skip to main content
. 2020 Sep;374(3):376–391. doi: 10.1124/jpet.120.265561

Fig. 7.

Fig. 7.

Agonist, antagonist, and opioid effects on dopamine D1 and D4.4 receptor–mediated adenylyl cyclase. (A) D1 agonist stimulation of adenylyl cyclase. (B) D1 antagonist inhibition of 100 nM dihydrexidine-stimulated adenylyl cyclase activity. (C) D4.4 agonist inhibition of 10 µM forskolin-stimulated adenylyl cyclase. (D) D4.4 antagonist reversal of 2 nM quinpirole inhibition of forskolin-stimulated adenylyl cyclase. Data shown are the means ± S.E.M. of three to six experiments.